Baseline HCV‐RNA levels in genotype 1 chronic hepatitis C patients: The role of different cut‐off points
Maria Buti, Juan J. Sánchez‐Ruano, Rosa M. Morillas, Rafael Esteban – 11 March 2016
Steatosis after liver transplantation: Is it really benign?
Armin Finkenstedt, Ivo W. Graziadei – 11 March 2016
Development and Validation of a Disease‐Specific Questionnaire to Assess Patient‐Reported Symptoms in Polycystic Liver Disease
Myrte K. Neijenhuis, Tom J.G. Gevers, Marie C. Hogan, Patrick S. Kamath, Titus F.M. Wijnands, Ralf C.P.M. van den Ouweland, Marie E. Edwards, Jeff A. Sloan, Wietske Kievit, Joost P.H. Drenth – 11 March 2016 – Treatment of polycystic liver disease (PLD) focuses on symptom improvement. Generic questionnaires lack sensitivity to capture PLD‐related symptoms, a prerequisite to determine effectiveness of therapy. We developed and validated a disease‐specific questionnaire that assesses symptoms in PLD (PLD‐Q).
Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?
Neil Mehta, John P. Roberts, Francis Y. Yao – 8 March 2016
Simultaneous implantation of bilateral liver grafts in living donor liver transplantation with fusion venoplasty
Albert C. Y. Chan, Kenneth S. H. Chok, Sui Ling Sin, Wing Chiu Dai, Tan To Cheung, See Ching Chan, Chung Mau Lo – 8 March 2016
Graft selection strategy in adult‐to‐adult living donor liver transplantation: When both hemiliver grafts meet volumetric criteria
Takeshi Kurihara, Tomoharu Yoshizumi, Yoshihiro Yoshida, Toru Ikegami, Shinji Itoh, Norifumi Harimoto, Mizuki Ninomiya, Hideaki Uchiyama, Hirohisa Okabe, Koichi Kimura, Hirofumi Kawanaka, Ken Shirabe, Yoshihiko Maehara – 8 March 2016 – To ensure donor safety in living donor liver transplantation (LDLT), the left and caudate lobe (LL) is the preferred graft choice. However, patient prognosis may still be poor even if graft volume (GV) selection criteria are met. Our aim was to evaluate the effects of right lobe (RL) donation when the LL graft selection criteria are met.
Use of a pressure wire to evaluate right heart pressures in a pre‐liver transplant recipient through a peripheral IV
Jeffrey M. Schussler, Sumeet K. Asrani, Michael A.E. Ramsay, James F. Trotter – 8 March 2016
Retinoids: The Link Between Alcohol and Interferon?
Steven A. Weinman, Irina Tikhanovich – 7 March 2016
Decisions on futility in patients with cirrhosis and organ failure
Mark J.W. McPhail, Georg Auzinger, William Bernal, Julia A. Wendon – 7 March 2016
The new liver allocation score for transplantation is validated and improved transplant survival benefit in Germany but not in the United Kingdom
Harald Schrem, Moritz Focken, Bridget Gunson, Benedikt Reichert, Darius Mirza, Hans‐Heinrich Kreipe, Desley Neil, Alexander Kaltenborn, Alon Goldis, Christian Krauth, Keith Roberts, Thomas Becker, Jürgen Klempnauer, James Neuberger – 7 March 2016 – Prognostic models for the prediction of 90‐day mortality after transplantation with pretransplant donor and recipient variables are needed to calculate transplant benefit.